NCT00141284
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
- Locations
-
- Pfizer Investigational Site Bakersfield, California, United States
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site Shreveport, Louisiana, United States
- Pfizer Investigational Site Dallas, Texas, United States